Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
Cescon DW, Schmid P, Rugo HS, Im SA, Md Yusof M, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Haiderali A, Zhou X, Guo Z, Nguyen AM, Cortes J.
Cescon DW, et al. Among authors: nguyen am.
J Natl Cancer Inst. 2024 May 8;116(5):717-727. doi: 10.1093/jnci/djad240.
J Natl Cancer Inst. 2024.
PMID: 38070159
Clinical Trial.